ABOS
Acumen Pharmaceuticals
$2.20
+$0.07 (+3.29%)Jul 27, 2026
Key metrics
The numbers that frame ABOS today
- Market cap
- $158.90M
- P/E (TTM)
- -1.4
- EV / FCF
- -1.3
- ROIC
- -109.9%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $1.19
- 52wk High
- $3.60
Growth
Revenue and earnings trend for ABOS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ABOS
Is Acumen Pharmaceuticals a good buy?
No. Acumen Pharmaceuticals has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Acumen Pharmaceuticals is selling at a very high price.
What is the market capitalization of ABOS?
Acumen Pharmaceuticals's market capitalization is $158.90M.
What is the P/E ratio for ABOS stock?
Acumen Pharmaceuticals's current P/E ratio is -1.4.
What is the 52-week high for ABOS stock?
The 52-week high for Acumen Pharmaceuticals is $3.60. The current close of $2.20 is 38.9% below that high.
What is the 52-week low for ABOS stock?
The 52-week low for Acumen Pharmaceuticals is $1.19. The current close of $2.20 is 84.9% above that low.
Does ABOS stock pay dividends?
Acumen Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ABOS?
Acumen Pharmaceuticals's Debt / Equity ratio is 0.36.